Paper810494
Comparison of three rocky mountain spotted fever vaccines.
Kenyon RH and 2 others. J Clin Microbiol, 1975. Cited by 24 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Comparison of three rocky mountain spotted fever vaccines. Papers, record 810494. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/810494
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Rickettsia rickettsii | Major topic |
| Rickettsial Vaccines | Major topic |
| Rocky Mountain Spotted Fever | Major topic |
| Vaccines | Major topic |
| Animals | |
| Antibody Formation | |
| Blood | |
| Cell Line | |
| Chick Embryo | |
| Ducks | |
| Female | |
| Guinea Pigs | |
| Haplorhini | |
| Macaca mulatta | |
| Vitelline Membrane |
Source PubMed
References7
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 4,387,631 | A microagglutination technique for detection and measurement of rickettsial antibodies. | Acta Virol | 1969 | https://conductscience.org/library/papers/4387631 | PubMed |
| 2 | 809,483 | Preparation of Rocky Mountain spotted fever vaccine suitable for human immunization. | J Clin Microbiol | 1975 | https://conductscience.org/library/papers/809483 | PubMed |
| 4 | 4,977,475 | Plaque assay for Rickettsia rickettsii. | J Bacteriol | 1969 | https://conductscience.org/library/papers/4977475 | PubMed |
| 5 | 4,629,203 | Plaque formation in tissue cultures by Rickettsia rickettsi isolated directly from whole blood and tick hemolymph. | Infect Immun | 1972 | https://conductscience.org/library/papers/4629203 | PubMed |
| 6 | 4,621,411 | Preparation of vaccines for Rocky Mountain spotted fever from rickettsiae propagated in cell culture. | J Infect Dis | 1972 | https://conductscience.org/library/papers/4621411 | PubMed |
| 7 | 4,199,563 | Rocky Mountain spotted fever: a comparative study of the active immunity induced by inactivated and viable pathogenic Rickettsia rickettsii. | J Infect Dis | 1973 | https://conductscience.org/library/papers/4199563 | PubMed |
| 8 | 4,866,101 | Method for counting Rickettsiae and Chlamydiae in purified suspensions. | J Bacteriol | 1968 | https://conductscience.org/library/papers/4866101 | PubMed |
Cited by14
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 24 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41,012,192 | What Stage Are We at in the Development of Vaccines Against Tick-Borne Diseases? | Vaccines (Basel) | 2025 | https://conductscience.org/library/papers/41012192 | PubMed |
| 41,011,829 | Silent Carriers: The Role of Rodents in the Emergence of Zoonotic Bacterial Threats. | Pathogens | 2025 | https://conductscience.org/library/papers/41011829 | PubMed |
| 40,750,591 | Vaccination-induced neutralizing antibodies in immunocompetent hosts correlate with protection against rickettsiae. | NPJ Vaccines | 2025 | https://conductscience.org/library/papers/40750591 | PubMed |
| 38,567,021 | Vaccine development: obligate intracellular bacteria new tools, old pathogens: the current state of vaccines against obligate intracellular bacteria. | Front Cell Infect Microbiol | 2024 | https://conductscience.org/library/papers/38567021 | PubMed |
| 36,298,491 | A Vaccine for Canine Rocky Mountain Spotted Fever: An Unmet One Health Need. | Vaccines (Basel) | 2022 | https://conductscience.org/library/papers/36298491 | PubMed |
| 34,452,021 | Vaccine Design and Vaccination Strategies against Rickettsiae. | Vaccines (Basel) | 2021 | https://conductscience.org/library/papers/34452021 | PubMed |
| 33,091,016 | The neglected challenge: Vaccination against rickettsiae. | PLoS Negl Trop Dis | 2020 | https://conductscience.org/library/papers/33091016 | PubMed |
| 25,043,277 | Phenotype of the anti-Rickettsia CD8(+) T cell response suggests cellular correlates of protection for the assessment of novel antigens. | Vaccine | 2014 | https://conductscience.org/library/papers/25043277 | PubMed |
| 21,687,751 | Adherence to and invasion of host cells by spotted Fever group rickettsia species. | Front Microbiol | 2010 | https://conductscience.org/library/papers/21687751 | PubMed |
| 21,444,665 | Molecular basis of immunity to rickettsial infection conferred through outer membrane protein B. | Infect Immun | 2011 | https://conductscience.org/library/papers/21444665 | PubMed |
| 19,837,287 | The realities of biodefense vaccines against Rickettsia. | Vaccine | 2009 | https://conductscience.org/library/papers/19837287 | PubMed |
| 823,173 | Effect of vaccination schedule on immune response of Macaca mulatta to cell culture-grown Rocky Mountain spotted fever vaccine. | J Clin Microbiol | 1976 | https://conductscience.org/library/papers/823173 | PubMed |
| 819,455 | Antibody response to Rocky Mountain spotted fever. | J Clin Microbiol | 1976 | https://conductscience.org/library/papers/819455 | PubMed |
| 114,488 | Exposure of guinea pigs to Rickettsia rickettsii by aerosol, nasal, conjunctival, gastric, and subcutaneous routes and protection afforded by an experimental vaccine. | Infect Immun | 1979 | https://conductscience.org/library/papers/114488 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/810494
GET https://conductscience.org/api/papers/v1/810494/authors